Filing search / Madrigal Pharmaceuticals, Inc. / "Litigation" / Page 8

424B2

fvjf6dovt2

3 May 13

Prospectus for primary offering

12:00am

424B5

ct1wi2k66446fgy

13 Dec 12

Prospectus supplement for primary offering

12:00am

8-K

EX-10.1

q4eemrzwvir7c

13 Dec 12

Synta Pharmaceuticals Announces $60 Million Registered Direct Common Stock Offering

12:00am

424B5

2zu ejn7q

26 Jul 12

Prospectus supplement for primary offering

12:00am

424B5

f1z5houeji er1gosnh

3 May 12

Prospectus supplement for primary offering

12:00am

424B5

9ug v8hkumuu

6 Jan 12

Prospectus supplement for primary offering

12:00am

8-K

EX-1.1

7m0vv

6 Jan 12

Synta Pharmaceuticals Prices Public Offering of Common Stock

12:00am

424B5

7vnis9uxrtb3v xf

5 Jan 12

Prospectus supplement for primary offering

12:00am

424B2

jlatw ajp9bu9m

19 Aug 11

Prospectus for primary offering

12:00am